Journal article icon

Journal article

Structural basis of human PRPS2 filaments

Abstract:
Abstract Background PRPP synthase (PRPS) transfers the pyrophosphate groups from ATP to ribose-5-phosphate to produce 5-phosphate ribose-1-pyrophosphate (PRPP), a key intermediate in the biosynthesis of several metabolites including nucleotides, dinucleotides and some amino acids. There are three PRPS isoforms encoded in human genome. While human PRPS1 (hPRPS1) and human PRPS2 (hPRPS2) are expressed in most tissues, human PRPS3 (hPRPS3) is exclusively expressed in testis. Although hPRPS1 and hPRPS2 share 95% sequence identity, hPRPS2 has been shown to be less sensitive to allosteric inhibition and specifically upregulated in certain cancers in the translational level. Recent studies demonstrate that PRPS can form a subcellular compartment termed the cytoophidium in multiple organisms across prokaryotes and eukaryotes. Forming filaments and cytoophidia is considered as a distinctive mechanism involving the polymerization of the protein. Previously we solved the filament structures of Escherichia coli PRPS (ecPRPS) using cryo-electron microscopy (cryo-EM) 1. Results Order to investigate the function and molecular mechanism of hPRPS2 polymerization, here we solve the polymer structure of hPRPS2 at 3.08 Å resolution. hPRPS2 hexamers stack into polymers in the conditions with the allosteric/competitive inhibitor ADP. The binding modes of ADP at the canonical allosteric site and at the catalytic active site are clearly determined. A point mutation disrupting the inter-hexamer interaction prevents hPRPS2 polymerization and results in significantly reduced catalytic activity. Conclusion Findings suggest that the regulation of hPRPS2 polymer is distinct from ecPRPS polymer and provide new insights to the regulation of hPRPS2 with structural basis
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1186/s13578-023-01037-z

Authors

More by this author
Role:
Author
ORCID:
0009-0009-2953-5838
More by this author
Role:
Author
ORCID:
0000-0002-0000-2415


More from this funder
Funder identifier:
10.13039/501100000265
Grant:
MC_UU_12021/3
More from this funder
Funder identifier:
10.13039/501100003399
Grant:
20JC1410500
More from this funder
Funder identifier:
10.13039/501100001809
Grant:
31771490
More from this funder
Funder identifier:
10.13039/501100002855
Grant:
2021YFA0804700


Publisher:
BioMed Central
Journal:
Cell & Bioscience More from this journal
Volume:
13
Issue:
1
Pages:
100-100
Article number:
100
Publication date:
2023-05-30
DOI:
EISSN:
2045-3701
ISSN:
2045-3701


Language:
English
Keywords:
Pubs id:
1347103
Local pid:
pubs:1347103
Source identifiers:
W4378746417
Deposit date:
2026-05-08
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP